Acro Biomedical Co., Ltd. Liquidation Value

ACBM Other

Cash & Equivalents

$4,098
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $4,098
Total Obligations: -$401,062
$-396,964
Per share: $-0.01
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $4,098
AR: $0
Total Obligations: -$401,062
$-396,964
Per share: $-0.01
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $4,098
AR: $0
Inventory: $0
Total Obligations: -$401,062
$-396,964
Per share: $-0.01
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-396,964$-0.01
Liquid Liquidation Value$-396,964$-0.01
Operating Liquidation Value$-396,964$-0.01

Key Components (as of 2025-12-31)

Cash & Equivalents$4,098
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$401,062
Long-term DebtN/A
Op. Lease Liability$0
Finance LeaseN/A
Shares Outstanding60.0M

Explore all 55 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$4,098N/AN/AN/A$401,062N/A$0N/A
2025-09-30$4,323N/AN/AN/A$436,942N/A$0N/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-11 View
2025-09-30 10-Q 2025-11-10 View
2025-06-30 10-Q 2025-08-05 View
2025-03-31 10-Q 2025-07-24 View
2024-12-31 10-K 2025-07-24 View
2024-09-30 10-Q 2025-07-23 View
2024-06-30 10-Q 2025-07-23 View
2024-03-31 10-Q 2025-07-22 View

Community Notes

Loading notes...

Questions

Loading questions...